Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
Stocks
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
13/11/2026
|
5-day change | 1st Jan Change | ||
| 39.65 CNY | -0.33% |
|
-5.86% | -13.09% |
| Market Cap | 25.98B 3.89B 3.53B 3.26B 2.94B 5.55B 367B 5.74B 39.19B 15.54B 196B 14.61B 14.3B 622B | P/E 2026 * |
29.6x | P/E 2027 * | 25.7x |
|---|---|---|---|---|---|
| Enterprise Value | 25.98B 3.89B 3.53B 3.26B 2.94B 5.55B 367B 5.74B 39.19B 15.54B 196B 14.61B 14.3B 622B | EV / Sales 2026 * |
5.27x | EV / Sales 2027 * | 4.86x |
| Free-Float |
31.71% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.33% | ||
| 1 week | -5.86% | ||
| Current month | -1.61% | ||
| 1 month | +10.14% | ||
| 3 months | +7.77% | ||
| 6 months | -9.14% | ||
| Current year | -13.09% |
| 1 week | 38.9 |  | 42.25 |
| 1 month | 36.3 | | 43.42 |
| Current year | 33.83 | | 48.2 |
| 1 year | 33.83 | | 49.15 |
| 3 years | 23.4 | | 50.97 |
| 5 years | 17.98 | | 56.26 |
| 10 years | 11.8 | | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hong Chen
CEO | Chief Executive Officer | 56 | 04/09/2026 |
Jian Ma
DFI | Director of Finance/CFO | 42 | - |
Hong Zhou
PRN | Corporate Officer/Principal | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Hong Zhou
BRD | Director/Board Member | 56 | 15/05/2019 |
Min Guo
CHM | Chairman | 55 | 06/09/2021 |
Jian Hua Xing
BRD | Director/Board Member | 55 | 10/12/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.33% | -5.86% | -19.64% | +29.24% | 3.89B | |
| +1.26% | +6.61% | +41.12% | +135.59% | 1,286B | |
| +0.79% | +3.45% | +46.35% | +93.56% | 688B | |
| +0.20% | +1.28% | +27.01% | +112.80% | 521B | |
| -0.44% | +3.69% | +39.60% | +69.51% | 386B | |
| +0.55% | +0.70% | +59.00% | +44.20% | 364B | |
| -0.12% | +0.74% | +26.78% | +58.43% | 302B | |
| +0.37% | +0.37% | +3.62% | +36.44% | 287B | |
| -0.30% | +1.14% | +38.59% | +74.61% | 252B | |
| +0.08% | +0.71% | +34.25% | +124.32% | 208B | |
| Average | +0.21% | +1.36% | +29.67% | +77.87% | 430B | |
| Weighted average by Cap. | +0.54% | +3.25% | +37.58% | +96.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.93B 739M 669M 619M 559M 1.05B 69.65B 1.09B 7.44B 2.95B 37.21B 2.77B 2.71B 118B | 5.35B 802M 726M 672M 606M 1.14B 75.59B 1.18B 8.07B 3.2B 40.38B 3.01B 2.94B 128B |
| Net income | 1.04B 155M 141M 130M 117M 221M 14.63B 229M 1.56B 620M 7.82B 582M 570M 24.81B | 1.18B 177M 161M 149M 134M 253M 16.72B 262M 1.79B 708M 8.93B 666M 652M 28.36B |
| Net Debt | - | - |
Employees
3,890
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | CN¥39.65 | -0.33% | 3,825,883 |
| 12/11/26 | CN¥39.78 | -0.67% | 4,907,604 |
| 11/11/26 | CN¥40.05 | -2.15% | 3,465,899 |
| 10/11/26 | CN¥40.93 | -2.01% | 3,264,700 |
| 09/11/26 | CN¥41.77 | -0.83% | 3,507,100 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
39.65
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
